[HTML][HTML] Therapeutic radionuclides in nuclear medicine: current and future prospects
CH Yeong, M Cheng, KH Ng - Journal of Zhejiang University …, 2014 - ncbi.nlm.nih.gov
The potential use of radionuclides in therapy has been recognized for many decades. A
number of radionuclides, such as iodine-131 (131 I), phosphorous-32 (32 P), strontium-90 …
number of radionuclides, such as iodine-131 (131 I), phosphorous-32 (32 P), strontium-90 …
Progress in emerging therapies for advanced prostate cancer
S Oudard - Cancer treatment reviews, 2013 - Elsevier
The landscape of prostate cancer treatment is rapidly changing as extensive research into
potential therapies yields new options. In this article, the literature is reviewed to identify …
potential therapies yields new options. In this article, the literature is reviewed to identify …
Treatment of bone metastasis with bone-targeting radiopharmaceuticals
JY Choi - Nuclear medicine and molecular imaging, 2018 - Springer
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and
results in serious symptoms and complications such as bone pain, pathological fractures …
results in serious symptoms and complications such as bone pain, pathological fractures …
Radiometabolic Treatment of Bone-Metastasizing Cancer: From 186Rhenium to 223Radium
G Rubini, A Nicoletti, D Rubini… - Cancer Biotherapy and …, 2014 - liebertpub.com
Skeletal metastases occur in many patients with different kinds of malignant tumors,
especially in advance stage of breast cancer (in 47%–85% of patients), prostate cancer (33 …
especially in advance stage of breast cancer (in 47%–85% of patients), prostate cancer (33 …
Metastatic tumours of bone
AK Freeman, VP Sumathi, L Jeys - Surgery (Oxford), 2018 - Elsevier
Metastatic tumours of the bone are the most common types of bone cancer. Autopsy studies
have shown that 70% of patients with breast and prostate carcinoma develop skeletal …
have shown that 70% of patients with breast and prostate carcinoma develop skeletal …
Targeted radionuclide therapy of painful bone metastases: past developments, current status, recent advances and future directions
A Dash, T Das, FFR Knapp - Current medicinal chemistry, 2020 - ingentaconnect.com
Bone pain arising from secondary skeletal malignancy constitutes one of the most common
types of chronic pain among patients with cancer which can lead to rapid deterioration of the …
types of chronic pain among patients with cancer which can lead to rapid deterioration of the …
New developments in castrate‐resistant prostate cancer
N Shore, M Mason, TM de Reijke - BJU international, 2012 - Wiley Online Library
Castrate‐resistant prostate cancer (CRPC) occurs when disease progresses in the presence
of castrate levels of androgens and remains sensitive to further hormonal manipulation. For …
of castrate levels of androgens and remains sensitive to further hormonal manipulation. For …
153Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies
L Correa-González, CA de Murphy… - Archives of medical …, 2014 - Elsevier
Background and Aims Approximately 85% of patients with cancer suffer severe metastatic
bone pain for which radionuclide therapy has been employed for pain palliation. We …
bone pain for which radionuclide therapy has been employed for pain palliation. We …
Reducing the burden of bone metastases: current concepts and treatment options
R von Moos, C Sternberg, JJ Body… - Supportive care in …, 2013 - Springer
Background Bone metastases occur frequently in patients with solid tumours such as those
of the prostate, breast and lung, and are associated with an increased risk of skeletal-related …
of the prostate, breast and lung, and are associated with an increased risk of skeletal-related …
[HTML][HTML] Investigation of 177Lu-labeled HEDP, DPD, and IDP as potential bone pain palliation agents
M Mirković, Z Milanović, D Stanković, Đ Petrović… - Journal of Radiation …, 2020 - Elsevier
Application of bone-seeking radiopharmaceuticals is one of the modalities in the
management of metastatic bone pain. The present study aimed to investigate the potential of …
management of metastatic bone pain. The present study aimed to investigate the potential of …